ACOPF Stock Chart & Stats
$4.92
$0.00(0.00%)
At close: 4:00 PM EDT
$4.92
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$3.40 - $7.38
Previous CloseN/A
Volume52.00
Average Volume (3M)142.00
Market Cap
$3.39B
Enterprise Value$5.94B
Total Cash (Recent Filing)$784.47M
Total Debt (Recent Filing)$24.31M
Price to Earnings (P/E)27.0
Beta-0.56
Next Earnings
Feb 22, 2027EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend Yield7.56%
Share Statistics
EPS (TTM)0.30
Shares Outstanding728,055,850
10 Day Avg. Volume52
30 Day Avg. Volume142
Financial Highlights & Ratios
PEG Ratio4.27
Price to Book (P/B)6.18
Price to Sales (P/S)3.36
P/FCF Ratio111.21
Enterprise Value/Market Cap1.75
Enterprise Value/Revenue3.01
Enterprise Value/Gross Profit6.32
Enterprise Value/Ebitda19.54
Forecast
1Y Price Target
$5.38Price Target Upside9.37% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)0.17
Revenue Forecast (FY)$1.17B
Bulls Say, Bears Say
Bulls Say
Strong Profitability And MarginsImproving gross and net margins indicate stronger profit capture across the branded portfolio and support reinvestment in innovation, marketing and distribution. Healthy operating profitability also provides resilience as the company manages product mix changes and rebuilds China demand.
Conservative Balance Sheet And LiquidityMinimal leverage and substantial liquidity give a2 Milk flexibility to fund product launches, supply-chain investment and market recovery without relying heavily on external financing. This strengthens resilience through execution cycles and preserves options for disciplined capital allocation.
Diversified Growth From Innovation And International MarketsGrowth across the U.S., liquid milk and other nutritionals reduces reliance on a single product-market combination and broadens the company’s earnings base. Innovation contributing over half of sales growth suggests the portfolio can keep opening categories and supporting brand relevance.
Bears Say
China-label Infant Formula Disruption And Share LossThe disruption caused lost availability and consumer switching to rival brands, creating a durable customer-retention challenge even after supply normalizes. Recovery depends on regaining former users and recruiting new ones, making China infant-formula earnings execution-sensitive.
Near-term Margin Pressure From Mix, Costs And ReinvestmentLower-margin mix, higher input costs and stepped-up marketing are expected to weigh on profitability while the company rebuilds China sales. Although spending may support recovery, the combination reduces margin headroom and makes earnings improvement dependent on successful execution.
Weaker Cash Conversion And Higher Cash OutflowsThe sharp decline in cash generation means reported earnings translated into less internally available funding in the latest year. Supply-chain transactions, Pokeno investment, inventory build and dividends further reduced cash, potentially constraining flexibility if recovery spending persists.
a2 Milk Company News
ACOPF FAQ
What was a2 Milk Company Ltd.’s price range in the past 12 months?
a2 Milk Company Ltd. lowest stock price was $3.40 and its highest was $7.38 in the past 12 months.
What is a2 Milk Company Ltd.’s market cap?
a2 Milk Company Ltd.’s market cap is $3.39B.
When is a2 Milk Company Ltd.’s upcoming earnings report date?
a2 Milk Company Ltd.’s upcoming earnings report date is Feb 22, 2027 which is in 132 days.
How were a2 Milk Company Ltd.’s earnings last quarter?
a2 Milk Company Ltd. released its earnings results on Aug 16, 2026. The company reported $0.074 earnings per share for the quarter, beating the consensus estimate of $0.072 by $0.002.
Is a2 Milk Company Ltd. overvalued?
According to Wall Street analysts a2 Milk Company Ltd.’s price is currently Undervalued.
Does a2 Milk Company Ltd. pay dividends?
a2 Milk Company Ltd. pays a Semiannually dividend of $0.054 which represents an annual dividend yield of 7.56%. See more information on a2 Milk Company Ltd. dividends here
What is a2 Milk Company Ltd.’s EPS estimate?
a2 Milk Company Ltd.’s EPS estimate is 0.07.
How many shares outstanding does a2 Milk Company Ltd. have?
a2 Milk Company Ltd. has 728,055,850 shares outstanding.
What happened to a2 Milk Company Ltd.’s price movement after its last earnings report?
a2 Milk Company Ltd. reported an EPS of $0.074 in its last earnings report, beating expectations of $0.072. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of a2 Milk Company Ltd.?
Currently, no hedge funds are holding shares in ACOPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
a2 Milk Company Ltd.
The a2 Milk Company Limited, along with its affiliated entities, distributes A2 protein-branded dairy products and related merchandise across key international markets including Australia, New Zealand, China, various other Asian territories, and the United States. Its core offerings include fresh milk, marketed under the "a2 Milk" brand, and infant formula, sold as "a2 Platinum." This Auckland, New Zealand-headquartered company was founded in 2000 and officially changed its name from A2 Corporation Limited to its present form in April 2014.
ACOPF Company Deck
ACOPF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a mixed picture: the company delivered strong top-line growth (+12.4%), solid underlying EBITDA and multiple growth vectors (U.S., ANZ, other nutritionals, innovation), completed strategic supply-chain moves (a2 Pokeno) and returned significant capital to shareholders. However, a material fourth-quarter supply-chain disruption severely impacted China label IMF sales and in-market availability, pressured reported margins and required elevated marketing and recovery spend. Management outlined a clear recovery plan and expects FY'27 growth weighted to the second half, but near-term margin and sales phasing remain challenged.View all ACOPF earnings summariesACOPF Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$5.38
▲(9.37% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Comvita
―
Synlait Milk Ltd.
―
Livestock Improvement Corporation Ltd
―
Scales Corp. Ltd.
―
T&G Global Limited
―
Ownership Overview
0.45% Insiders
3.31% Mutual Funds
<0.01% Other Institutional Investors
92.05% Public Companies and
Individual Investors







